We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PLBC:NASDAQPlumas Bancorp Analysis

Data as of 2026-04-24 - not real-time

$51.25

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Plumas Bancorp’s stock is trading at $51.25, comfortably above its 20‑day ($50.72) and 50‑day ($50.45) moving averages and well above the 200‑day level ($45.57), signaling a sustained bullish trend. The RSI sits near the mid‑range at 54, while the MACD histogram remains positive, reinforcing the upward momentum. Technical support around $48.01 provides a cushion, and the next resistance near $54.21 offers upside potential of roughly 6% before hitting the 52‑week high. Fundamentally, the company posted a 32% revenue surge year‑over‑year, with operating margins exceeding 50% and a profit margin of 33%, highlighting strong earnings power. At a trailing P/E of 10.9 versus an industry average of 17.3, the stock appears undervalued, and a forward P/E of 8.9 suggests further discounting ahead of earnings growth. The board’s recent declaration of a $0.33 quarterly cash dividend, yielding about 2.55% with a modest 26% payout ratio, underscores a sustainable income stream for shareholders.
The balance sheet shows $62.9 M in cash offsetting $144 M of debt, and a beta near 0.8 points to lower volatility than the broader market, though recent volume trends are decreasing. Volatility over the past 30 days sits at 16%, indicating moderate price swings. Analyst consensus is a “Buy” with a median price target of $60, implying roughly 17% upside. Combined, the technical strength, attractive valuation, solid growth metrics, and reliable dividend make PLBC a compelling candidate for investors seeking both value and growth exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup with price above key moving averages
  • Undervalued relative to industry P/E
  • Attractive dividend yield and sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • Forward P/E compression indicating earnings expansion
  • Analyst price targets suggesting ~17% upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent profitability and solid ROE
  • Sustainable dividend policy enhancing total return
  • Moderate beta and manageable balance‑sheet leverage

Key Metrics & Analysis

Financial Health

Revenue Growth32.40%
Profit Margin32.72%
P/E Ratio10.9
ROE14.22%
ROA1.68%
P/B Ratio1.4
Industry P/E17.3

Technical Analysis

TrendBullish
RSI54.3
Support$48.01
Resistance$54.21
MA 20$50.72
MA 50$50.45
MA 200$45.57
MACDBullish
VolumeDecreasing
Fear & Greed Index88.02

Valuation

Target Price$60.33
Upside/Downside17.72%
GradeUndervalued
TypeBlend
Dividend Yield2.55%

Risk Assessment

Beta0.80
Volatility16.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.